Tumor interactions with the vasculature: angiogenesis and tumor metastasis.

[1]  P. Polverini,et al.  Induction of Neovascularization and Nonlymphoid Mesenchymal Cell Proliferation by Macrophage Cell Lines , 1985, Journal of leukocyte biology.

[2]  R. Stern,et al.  Elastases in human breast carcinoma cell lines. , 1986, Cancer research.

[3]  J. Folkman,et al.  Tumor angiogenesis: iris neovascularization at a distance from experimental intraocular tumors. , 1973, Journal of the National Cancer Institute.

[4]  T. Irimura,et al.  The role of fibronectin in adhesion of metastatic melanoma cells to endothelial cells and their basal lamina. , 1981, Experimental cell research.

[5]  J. Keller,et al.  Correlation between cell substrate attachment in vitro and cell surface heparan sulfate affinity for fibronectin and collagen , 1983, The Journal of cell biology.

[6]  A. Janoff.  Elastase in tissue injury. , 1985, Annual review of medicine.

[7]  D. Ausprunk,et al.  Proteoglycans in the microvascular. II. Histochemical localization in proliferating capillaries of the rabbit cornea. , 1981, The American journal of pathology.

[8]  H. Kleinman,et al.  YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. , 1987, Science.

[9]  Z. Werb,et al.  Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression , 1989, The Journal of cell biology.

[10]  A. J. Valente,et al.  Identification of monocyte chemotactic activity produced by malignant cells. , 1989, Science.

[11]  V. Knick,et al.  In vitro cytotoxicity expressed by cells active against established tumors in vivo. , 1981, Cancer research.

[12]  M. Sporn,et al.  Some recent advances in the chemistry and biology of transforming growth factor-beta , 1987, The Journal of cell biology.

[13]  L. Ossowski.  Plasminogen activator dependent pathways inthe dissemination of human tumor cells in the chick embryo , 1988, Cell.

[14]  G. Conn,et al.  The isolation and purification of two anionic endothelial cell growth factors from human brain. , 1984, Biochemical and biophysical research communications.

[15]  J. Baker,et al.  Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin , 1988, The Journal of cell biology.

[16]  D. Ausprunk,et al.  Proteoglycans in the microvasculature. I. Histochemical localization in microvessels of the rabbit eye. , 1981, The American journal of pathology.

[17]  E. Appella,et al.  Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. , 1988, Cancer research.

[18]  Z. Werb,et al.  Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates. , 1985, The Journal of biological chemistry.

[19]  Sugarbaker Ev.  Some characteristics of metastasis in man. , 1979, The American journal of pathology.

[20]  R. Kramer,et al.  Selective degradation of basement membrane macromolecules by metastatic melanoma cells. , 1984, Journal of the National Cancer Institute.

[21]  H. Dvorak,et al.  Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. , 1983, Cancer research.

[22]  H. Dvorak,et al.  Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[23]  G. Nicolson,et al.  Purification and some properties of a lung-derived growth factor that differentially stimulates the growth of tumor cells metastatic to the lung. , 1989, Cancer research.

[24]  S. Segal,et al.  Differences in resistance of metastatic tumor cells and cells from local tumor growth to cytotoxicity of natural killer cells. , 1979, Journal of the National Cancer Institute.

[25]  L Orci,et al.  In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices , 1983, The Journal of cell biology.

[26]  S. Szabó,et al.  A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. , 1985, Science.

[27]  J. L. Swain,et al.  Tissue distribution and developmental expression of the messenger RNA encoding angiogenin. , 1987, Science.

[28]  G. Markus,et al.  Plasminogen activator activity and composition in human breast cancer. , 1982, Cancer research.

[29]  Bonnie F. Sloane,et al.  Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential. , 1982, Cancer research.

[30]  P. Waterhouse,et al.  Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. , 1989, Science.

[31]  L. Weiss.  The hemodynamic destruction of circulating cancer cells. , 1987, Biorheology.

[32]  G. Nicolson,et al.  Chemotactic response of rat mammary adenocarcinoma cell clones to tumor-derived cytokines. , 1987, Biochemical and biophysical research communications.

[33]  L. Liotta,et al.  Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. , 1974, Cancer research.

[34]  G. Giménez-Gallego,et al.  Fibroblast growth factors: broad spectrum mitogens with potent angiogenic activity , 1986 .

[35]  S. Brem,et al.  Angiogenesis as a marker of preneoplastic lesions of the human breast , 1978, Cancer.

[36]  C. Hoch‐Ligeti,et al.  Association of tissue mast cells and skin tumors. , 1961, Archives of dermatology.

[37]  J. Starkey,et al.  Mast‐cell‐deficient W/Wv mice exhibit A decreased rate of tumor angiogenesis , 1988, International journal of cancer.

[38]  J. Folkman,et al.  The effect of fibrin on cultured vascular endothelial cells. , 1979, Tissue & cell.

[39]  L. Liotta,et al.  Adhesion characteristics of murine metastatic and nonmetastatic tumor cells in vitro. , 1980, Cancer research.

[40]  P. Vaupel,et al.  Purified monocyte-derived angiogenic substance (angiotropin) induces controlled angiogenesis associated with regulated tissue proliferation in rabbit skin. , 1988, The Journal of clinical investigation.

[41]  M J Banda,et al.  Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. , 1988, Science.

[42]  D. De Rijk,et al.  Involvement of LFA-1 in lymphoma invasion and metastasis demonstrated with LFA-1-deficient mutants , 1989, The Journal of cell biology.

[43]  J. Folkman,et al.  Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. , 1977, Microvascular research.

[44]  T. Irimura,et al.  Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. , 1984, The Journal of biological chemistry.

[45]  J. Glowacki,et al.  Mast cells in hemangiomas and vascular malformations. , 1982, Pediatrics.

[46]  P. Jones,et al.  Degradation of the subendothelial matrix by tumor cells. , 1983, Cancer research.

[47]  D. Connolly,et al.  Vascular permeability factor, an endothelial cell mitogen related to PDGF. , 1989, Science.

[48]  J. Riley.  The relationship of the tissue mast cells to the blood vessels in the rat. , 1953, The Journal of pathology and bacteriology.

[49]  R. Derynck,et al.  Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. , 1986, Science.

[50]  G. Giménez-Gallego,et al.  Human brain-derived acidic and basic fibroblast growth factors: amino terminal sequences and specific mitogenic activities. , 1986, Biochemical and biophysical research communications.

[51]  D. Rifkin,et al.  Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture , 1989, The Journal of cell biology.

[52]  Michael Loran Dustin,et al.  Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells , 1988, The Journal of cell biology.

[53]  B. Zetter.  [11] Assay of capillary endothelial cell migration , 1987 .

[54]  G. Eaves.  The invasive growth of malignant tumours as a purely mechanical process , 1973, The Journal of pathology.

[55]  D. Dowbenko,et al.  Cloning of a lymphocyte homing receptor reveals a lectin domain , 1989, Cell.

[56]  D. Gospodarowicz,et al.  Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin , 1978, The Journal of cell biology.

[57]  P. Gullino,et al.  Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. , 1975, Cancer research.

[58]  L. Lasky,et al.  Characterization of a human homologue of the murine peripheral lymph node homing receptor , 1989, The Journal of cell biology.

[59]  D. Tarin,et al.  Influence of microenvironment and vascular anatomy on "metastatic" colonization potential of mammary tumors. , 1981, Cancer research.

[60]  H. Dvorak,et al.  Tumor shedding and coagulation. , 1981, Science.

[61]  R. Langer,et al.  Isolations of a cartilage factor that inhibits tumor neovascularization. , 1976, Science.

[62]  S. Karpatkin,et al.  Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice. , 1984, Cancer research.

[63]  M. Klagsbrun,et al.  Purification of cartilage-derived growth factor by heparin affinity chromatography. , 1985, The Journal of biological chemistry.

[64]  J. Quigley,et al.  Fibronectin enhancement of directed migration of B16 melanoma cells. , 1984, Cancer research.

[65]  B. Zetter,et al.  Melanoma cell adhesion to defined extracellular matrix components. , 1986, Biochemical and biophysical research communications.

[66]  F. Orr,et al.  Adhesion, chemotaxis, and aggregation of Walker carcinosarcoma cells in response to products of resorbing bone. , 1985, Journal of the National Cancer Institute.

[67]  J. Folkman,et al.  Toward an Understanding of Angiogenesis: Search and Discovery , 2015, Perspectives in biology and medicine.

[68]  R. Stern,et al.  Elastin degradation by proteases from cultured human breast cancer cells. , 1982, Biochemical and biophysical research communications.

[69]  P. Cuatrecasas,et al.  Chemical identification of a tumor-derived angiogenic factor. , 1987, Science.

[70]  L. Liotta,et al.  The elastin receptor shows structural and functional similarities to the 67-kDa tumor cell laminin receptor. , 1989, The Journal of biological chemistry.

[71]  B. Zetter,et al.  Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow. , 1989, The Journal of clinical investigation.

[72]  R. Iozzo,et al.  Neoplastic modulation of extracellular matrix: Stimulation of chondroitin sulfate proteoglycan and hyaluronic acid synthesis in co‐cultures of human colon carcinoma and smooth muscle cells , 1989, Journal of cellular biochemistry.

[73]  Wen‐Tien Chen,et al.  Fibronectin-degrading proteases from the membranes of transformed cells , 1987, Cell.

[74]  K. Yanagihara,et al.  Transformation by oncogenes encoding protein kinases induces the metastatic phenotype. , 1987, Science.

[75]  J. Folkman,et al.  Anti‐Angiogenesis: New Concept for Therapy of Solid Tumors , 1972, Annals of surgery.

[76]  P. Morméde,et al.  Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor. , 1985, Biochemical and biophysical research communications.

[77]  I. Fidler,et al.  Metastasis: Quantitative Analysis of Distribution and Fate of Tumor Emboli Labeled With 125I-5-Iodo-2′ -deoxyuridine , 1970 .

[78]  D. Tarín.  Clinical and experimental studies on the biology of metastasis. , 1985, Biochimica et biophysica acta.

[79]  D. Rifkin,et al.  Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. , 1988, Biochimica et biophysica acta.

[80]  S. Kumar,et al.  Tumour angiogenesis factor (TAF) in human and animal tumours , 1976, International journal of cancer.

[81]  F. Becker,et al.  Growth and metastasis of tumor in organ culture , 1963, Cancer.

[82]  R. Cotran,et al.  Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. , 1985, The Journal of clinical investigation.

[83]  R. Langer,et al.  Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. , 1983, Science.

[84]  Donald E. Ingber,et al.  How does extracellular matrix control capillary morphogenesis? , 1989, Cell.

[85]  M. Poupon,et al.  Differential adhesiveness of rhabdomyosarcoma-derived cloned metastatic cell lines to vascular endothelial monolayers. , 1986, Cancer research.

[86]  A. Vaheri,et al.  Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants , 1989, The Journal of cell biology.

[87]  R. Langer,et al.  Angiogenesis capacity as a diagnostic marker for human eye tumors. , 1979, Surgery.

[88]  P. Brodt.  Characterization of two highly metastatic variants of Lewis lung carcinoma with different organ specificities. , 1986, Cancer research.

[89]  J. Folkman,et al.  Protamine is an inhibitor of angiogenesis , 1982, Nature.

[90]  A. Lichtenstein.  Stimulation of the respiratory burst of murine peritoneal inflammatory neutrophils by conjugation with tumor cells. , 1987, Cancer research.

[91]  S. Barondes,et al.  The elastin receptor: a galactoside-binding protein. , 1988, Science.

[92]  A. Partin,et al.  Time lapse videomicroscopic identification of Dunning R-3327 adenocarcinoma and normal rat prostate cells. , 1987, The Journal of urology.

[93]  J. Folkman,et al.  The sequence of events in the regression of corneal capillaries. , 1978, Laboratory investigation; a journal of technical methods and pathology.

[94]  Bonnie F. Sloane,et al.  Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants. , 1987, Cancer research.

[95]  D. Rifkin,et al.  Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade , 1986, Cell.

[96]  M. Sporn,et al.  Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. , 1983, The Journal of biological chemistry.

[97]  J. Weiss,et al.  Partial purification of a 5.7K glycoprotein from bovine vitreous which inhibits both angiogenesis and collagenase activity. , 1985, Biochemical and biophysical research communications.

[98]  J. Folkman,et al.  Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. , 1984, Science.

[99]  L. Liotta,et al.  Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a. , 1987, Cancer research.

[100]  J. Richie,et al.  Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines. , 1980, Cancer research.

[101]  Y. Courtois,et al.  A unique family of endothelial cell polypeptide mitogens: the antigenic and receptor cross-reactivity of bovine endothelial cell growth factor, brain-derived acidic fibroblast growth factor, and eye-derived growth factor-II , 1985, The Journal of cell biology.

[102]  D. Ingber,et al.  A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution. , 1986, Endocrinology.

[103]  P. Gullino,et al.  Role of prostaglandin E1 and copper in angiogenesis. , 1982, Journal of the National Cancer Institute.

[104]  R. Hynes,et al.  Changes in integrin receptors on oncogenically transformed cells , 1989, Cell.

[105]  L. Liotta,et al.  Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro. , 1982, Journal of the National Cancer Institute.

[106]  Bonnie F. Sloane,et al.  Inhibition by dihydropyridine class calcium channel blockers of tumor cell-platelet-endothelial cell interactions in vitro and metastasis in vivo. , 1985, Biochemical pharmacology.

[107]  G. Peters,et al.  Potential oncogene product related to growth factors , 1987, Nature.

[108]  J E Talmadge,et al.  Evidence for a novel gene associated with low tumor metastatic potential. , 1988, Journal of the National Cancer Institute.

[109]  M. Young,et al.  Relationships between morphology, dissemination, migration, and prostaglandin E2 secretion by cloned variants of Lewis lung carcinoma. , 1985, Cancer research.

[110]  L. Stoolman.  Adhesion molecules controlling lymphocyte migration , 1989, Cell.

[111]  L. Ostrowski,et al.  Selective inhibition of proteolytic enzymes in an in vivo mouse model for experimental metastasis. , 1986, Cancer research.

[112]  I. Fidler,et al.  Immune stimulation-inhibition of experimental cancer metastasis. , 1974, Cancer research.

[113]  W. Risau,et al.  Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. , 1988, Developmental biology.

[114]  L. Liotta,et al.  Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells – role in metastasis , 1982, International journal of cancer.

[115]  J. Varani,et al.  Stimulation of murine tumour cell motility by laminin. , 1984, Journal of cell science.

[116]  Y. Iwamoto,et al.  Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. , 1988, Cancer research.

[117]  R. Auerbach,et al.  Tumor cells are protected from NK‐cell‐mediated lysis by adhesion to endothelial cells , 1988, International journal of cancer.

[118]  D. Glaves.  Correlation between circulating cancer cells and incidence of metastases. , 1983, British Journal of Cancer.

[119]  H. Dvorak,et al.  Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. , 1988, The American journal of pathology.

[120]  L. Liotta,et al.  Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. , 1989, Cancer research.

[121]  K. Miyazono,et al.  Purification and properties of an endothelial cell growth factor from human platelets. , 1987, The Journal of biological chemistry.

[122]  N. Ling,et al.  Isolation and partial characterization of an endothelial cell growth factor from the bovine kidney: homology with basic fibroblast growth factor , 1985, Regulatory Peptides.

[123]  D. Lawrence,et al.  Normal embryo fibroblasts release transforming growth factors in a latent form , 1984, Journal of cellular physiology.

[124]  D M Gersten,et al.  The biology of cancer invasion and metastasis. , 1978, Advances in cancer research.

[125]  R. Iozzo.  Proteoglycans: structure, function, and role in neoplasia. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[126]  N. Ling,et al.  Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. , 1987, Biochemical and biophysical research communications.

[127]  K. Takenaga.  Enhanced metastatic potential of cloned low-metastatic Lewis lung carcinoma cells treated in vitro with dimethyl sulfoxide. , 1984, Cancer research.

[128]  L. Reid,et al.  Clonal growth of tumors on tissue-specific biomatrices and correlation with organ site specificity of metastases. , 1989, Cancer research.

[129]  N. Sorgente,et al.  The resistance of certain tissues to invasion: penetrability of explanted tissues by vascularized mesenchyme. , 1973, The American journal of pathology.

[130]  T. Saruta,et al.  Numerous mast cells in an 11-deoxycorticosterone-producing adrenocortical tumor. Histologic evaluation of benignancy and comparison with mast cell distribution in adrenal glands and neoplastic counterparts of 67 surgical specimens. , 1985, Archives of pathology & laboratory medicine.

[131]  I. Carr,et al.  The ultrastructure and permeability characteristics of the blood vessels of a transplantable rat sarcoma , 1972, The Journal of pathology.

[132]  G. Rice,et al.  Tumor cell-endothelial interactions. Increased adhesion of human melanoma cells to activated vascular endothelium. , 1988, The American journal of pathology.

[133]  Richard O. Hynes,et al.  Integrins: A family of cell surface receptors , 1987, Cell.

[134]  Bonnie F. Sloane,et al.  Arrest and extravasation of B16 amelanotic melanoma in murine lungs. A light and electron microscopic study. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[135]  J. Folkman,et al.  Angiogenic Activity as a Marker of Neoplastic and Preneoplastic Lesions of the Human Bladder , 1980, Annals of surgery.

[136]  J. Glowacki,et al.  An ultrastructural study of mast cell interactions in hemangiomas. , 1986, Ultrastructural pathology.

[137]  J. Abecassis,et al.  The collagenase gene family in humans consists of at least four members. , 1988, The Biochemical journal.

[138]  J. Dingle,et al.  Cathepsins BI and D. Action on human cartilage proteoglycans. , 1973, Biochimica et biophysica acta.

[139]  Ferguson Gp,et al.  Mechanisms of neovascularization. Vascular sprouting can occur without proliferation of endothelial cells. , 1984 .

[140]  E. Engvall,et al.  The human laminin receptor is a member of the integrin family of cell adhesion receptors. , 1988, Science.

[141]  C. Baroni.  On the Relationship of Mast Cells to Various Soft Tissue Tumours , 1964, British Journal of Cancer.

[142]  L. Hood,et al.  Rat transforming growth factor type 1: structure and relation to epidermal growth factor. , 1984, Science.

[143]  R C Wagner,et al.  The isolation and culture of capillary endothelium from epididymal fat. , 1975, Microvascular research.

[144]  M. Knoth,et al.  Choriocarcinoma. Transfilter stimulation of vasoproliferation in the hamster cheek pouch. Studied by light and electron microscopy. , 1968, Journal of the National Cancer Institute.

[145]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[146]  J. McCarthy,et al.  Stimulation of haptotaxis and migration of tumor cells by serum spreading factor. , 1985, Cancer research.

[147]  B. Zetter,et al.  The cellular basis of site-specific tumor metastasis. , 1990, The New England journal of medicine.

[148]  M. Sporn,et al.  Transforming growth factor beta. , 1988, Advances in cancer research.

[149]  J. Folkman,et al.  Mast cells and tumor angiogenesis , 1976, International journal of cancer.

[150]  L. Liotta,et al.  Role of laminin receptor in tumor cell migration. , 1987, Cancer research.

[151]  P. Burbelo,et al.  The laminin B2 chain promoter contains unique repeat sequences and is active in transient transfection. , 1988, The Journal of biological chemistry.

[152]  R. Lobb,et al.  Purification of two distinct growth factors from bovine neural tissue by heparin affinity chromatography. , 1984, Biochemistry.

[153]  H. Dvorak,et al.  A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. , 1986, Cancer research.

[154]  L. Ossowski,et al.  In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase , 1988, The Journal of cell biology.

[155]  R. Langer,et al.  Purification and partial amino acid sequence of a bovine cartilage-derived collagenase inhibitor. , 1986, The Journal of biological chemistry.

[156]  E. Roos,et al.  Involvement of leukocyte function-associated antigen-1 (LFA-1) in the invasion of hepatocyte cultures by lymphoma and T-cell hybridoma cells , 1987, The Journal of cell biology.

[157]  M. Wicha,et al.  Metastatic potential of murine fibrosarcoma cells is influenced by cell surface laminin , 1984, International journal of cancer.

[158]  B. Pauli,et al.  Organ preference of metastasis. The role of organ-specifically modulated endothelial cells. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[159]  S. Nakamura,et al.  AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. , 1989, Science.

[160]  J. L. Bethune,et al.  Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. , 1985, Biochemistry.

[161]  L. Liotta,et al.  Metalloproteinases and malignant conversion: does correlation imply causality? , 1989, Journal of the National Cancer Institute.

[162]  M. Greenblatt,et al.  Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparent chamber technique. , 1968, Journal of the National Cancer Institute.

[163]  T. Maciag,et al.  Organizational behavior of human umbilical vein endothelial cells , 1982, The Journal of cell biology.

[164]  B. Zetter,et al.  Membrane-bound protein kinase C modulates receptor affinity and chemotactic responsiveness of Lewis lung carcinoma sublines to an elastin-derived peptide. , 1989, The Journal of biological chemistry.

[165]  A. Vaheri,et al.  Ultrastructural localization of plasma membrane-associated urokinase- type plasminogen activator at focal contacts , 1988, The Journal of cell biology.

[166]  K. Danø,et al.  immunocytochemical localization of urokinase-type plasminogen activator in lewis lung carcinoma , 1984, The Journal of cell biology.

[167]  L. Liotta,et al.  Activation of human breast carcinoma collagenase through plasminogen activator. , 1980, Life sciences.

[168]  A. Albini,et al.  Enhanced chemotaxis of tumor‐derived and virus‐transformed cells to fibronectin and fibroblast‐conditioned medium , 1984, International journal of cancer.

[169]  E. Chen,et al.  Human transforming growth factor-α: Precursor structure and expression in E. coli , 1984, Cell.

[170]  G. Markus,et al.  Content and characterization of plasminogen activators in human lung tumors and normal lung tissue. , 1980, Cancer research.

[171]  D. Gospodarowicz,et al.  Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cells. , 1987, Biochemical and biophysical research communications.

[172]  J. Quigley,et al.  The extracellular matrix of normal chick embryo fibroblasts: its effect on transformed chick fibroblasts and its proteolytic degradation by the transformants , 1985, The Journal of cell biology.

[173]  N. Ling,et al.  Primary structure of bovine brain acidic fibroblast growth factor (FGF). , 1985, Biochemical and biophysical research communications.

[174]  L. Liotta,et al.  Role of laminin in the attachment and metastasis of murine tumor cells. , 1982, Cancer research.

[175]  H. Greene.  HETEROLOGOUS TRANSPLANTATION OF MAMMALIAN TUMORS I. THE TRANSFER OF RABBIT TUMORS TO ALIEN SPECIES , 1941 .

[176]  P. Burger,et al.  Corneal neovascularization as studied by scanning electron microscopy of vascular casts. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[177]  L. Ossowski,et al.  Antibodies to plasminogen activator inhibit human tumor metastasis , 1983, Cell.

[178]  Z. Fuks,et al.  Tumor cell attachment to the vascular endothelium and subsequent degradation of the subendothelial extracellular matrix. , 1982, Experimental cell research.

[179]  J. Folkman,et al.  Tumor‐induced angiogenesis: Lack of inhibition by irradiation , 1975, International journal of cancer.

[180]  P. Gullino,et al.  Angiogenesis and neoplastic progression in vitro. , 1982, Journal of the National Cancer Institute.

[181]  L. Liotta,et al.  Basement membrane collagen: degradation by migrating endothelial cells. , 1983, Science.

[182]  K. Danø,et al.  Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.

[183]  G. Alessandri,et al.  Inhibition of tumor angiogenesis by hexuronyl hexosaminoglycan sulfate , 1986, Cancer.

[184]  P. Jones,et al.  Destruction of extracellular matrices containing glycoproteins, elastin, and collagen by metastatic human tumor cells. , 1980, Cancer research.

[185]  L. Liotta,et al.  Modulation of the metastatic activity of melanoma cells by laminin and fibronectin. , 1984, Science.

[186]  D. Belin,et al.  A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase , 1985, The Journal of cell biology.

[187]  R. Auerbach,et al.  A new microtechnique for quantitating cell movement in vitro using polystyrene bead monolayers. , 1984, Journal of immunological methods.

[188]  L. Liotta,et al.  Pertussis toxin inhibits stimulated motility independently of the adenylate cyclase pathway in human melanoma cells. , 1987, Biochemical and biophysical research communications.

[189]  N. Hanna,et al.  The role of natural killer cells in the control of tumor growth and metastasis. , 1985, Biochimica et biophysica acta.

[190]  Bonnie F. Sloane,et al.  Platelet enhancement of tumor cell adhesion to subendothelial matrix: role of platelet cytoskeleton and platelet membrane. , 1987, Journal of the National Cancer Institute.

[191]  B. Beutler,et al.  Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells , 1985, The Journal of experimental medicine.

[192]  M. Key,et al.  Partial purification and characterization of a vascular permeability factor secreted by a human colon adenocarcinoma cell line , 1985, International journal of cancer.

[193]  R. Weinberg,et al.  Basic fibroblast growth factor fused to a signal peptide transforms cells , 1988, Nature.

[194]  H U Keller,et al.  Locomotion of tumor cells as an element of invasion and metastasis. , 1987, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[195]  S. Larsson,et al.  Fibrinolysis in human Bronchogenic Carcinoma. , 1975, European journal of cancer.

[196]  M. Klagsbrun,et al.  Purification and characterization of heparin-binding endothelial cell growth factors. , 1986, The Journal of biological chemistry.

[197]  J. Folkman,et al.  SELF-REGULATION OF GROWTH IN THREE DIMENSIONS , 1973, The Journal of experimental medicine.

[198]  E. R. Clark,et al.  Observations on living preformed blood vessels as seen in a transparent chamber inserted into the rabbit's ear† , 1932 .

[199]  A. Ordinas,et al.  Tumor‐cell‐induced platelet aggregation is a glycoprotein‐dependent and lipoxygenase‐associated process , 1987, International journal of cancer.

[200]  G. Nicolson,et al.  Organ specificity of metastatic tumor colonization is related to organ‐selective growth properties of malignant cells , 1986, International journal of cancer.

[201]  M. J. Banda,et al.  Wound fluid angiogenesis factor stimulates the directed migration of capillary endothelial cells , 1985, Journal of cellular biochemistry.

[202]  V. Dixit,et al.  Tumor type‐specific differences in cell‐substrate adhesion among human tumor cell lines , 1987, International journal of cancer.

[203]  M. Klagsbrun,et al.  Stimulation of increased capillary endothelial cell motility by chondrosarcoma cell-derived factors. , 1983, Cancer research.

[204]  P. B. Weisz,et al.  Control of angiogenesis with synthetic heparin substitutes. , 1989, Science.

[205]  R. Schultz,et al.  Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. , 1988, Cancer research.

[206]  V. Terranova,et al.  Migration of tumor cells to organ-derived chemoattractants. , 1985, Cancer research.

[207]  K. Mann,et al.  Tumor cell generation of thrombin via functional prothrombinase assembly. , 1985, Cancer research.

[208]  L. Liotta,et al.  Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells. , 1983, The Journal of biological chemistry.

[209]  O. Petersen.  Spontaneous course of cervical precancerous conditions. , 1956, American journal of obstetrics and gynecology.

[210]  I. Weissman,et al.  Mouse lymph node homing receptor cDNA clone encodes a glycoprotein revealing tandem interaction domains. , 1989, Science.

[211]  A. Baird,et al.  Inhibition of endothelial cell proliferation by type beta-transforming growth factor: interactions with acidic and basic fibroblast growth factors. , 1986, Biochemical and biophysical research communications.

[212]  Gary R. Grotendorst,et al.  TGF-β inhibition of endothelial cell proliferation: Alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression , 1987, Cell.

[213]  Stuart K Williams,et al.  Capillary endothelial cell cultures: phenotypic modulation by matrix components , 1983, The Journal of cell biology.

[214]  A. Cerami,et al.  Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses , 1988, The Journal of cell biology.

[215]  R. Guillemin,et al.  Retina- and eye-derived endothelial cell growth factors: partial molecular characterization and identity with acidic and basic fibroblast growth factors. , 1985, Biochemistry.

[216]  H. Moses,et al.  Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor. , 1984, Science.

[217]  L. Liotta,et al.  Proteolytic Enzymes in Cancer Invasion and Metastasis , 1986, Seminars in thrombosis and hemostasis.

[218]  B. Zetter,et al.  Stimulation of rat peritoneal mast cell migration by tumor-derived peptides. , 1983, Cancer research.

[219]  David Barnes,et al.  Serum-free cell culture: a unifying approach , 1980, Cell.

[220]  M. Schwab,et al.  Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease , 1988, The Journal of cell biology.

[221]  W. Birchmeier,et al.  Transforming growth factor-beta inhibits endothelial cell proliferation. , 1986, Biochemical and biophysical research communications.

[222]  R. Knapp,et al.  The role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma. , 1972, Cancer research.

[223]  C. P. Leblond,et al.  Immunoelectron microscopy of endothelial cells in rat incisor suggests that most basement membrane components are produced by young cells, whereas heparan sulfate proteoglycan is produced by both young and old cells. , 1988, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[224]  I. Gresser.  Antitumor effects of interferon. , 1989, Acta oncologica.

[225]  A. Tulp,et al.  Interactions between lymphoid tumor cells and isolated liver endothelial cells. , 1984, Journal of the National Cancer Institute.

[226]  J. Quigley,et al.  An anticatalytic monoclonal antibody to avian plasminogen activator: Its effect on behavior of RSV-transformed chick fibroblasts , 1986, Cell.

[227]  M. Poupon,et al.  Enhancement of pulmonary metastases induced by decreased lung natural killer cell activity. , 1986, Journal of the National Cancer Institute.

[228]  J. Seltzer,et al.  H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. , 1988, The Journal of biological chemistry.

[229]  G. Gillespie,et al.  Studies on the role of macrophages in regulation of growth and metastasis of murine chemically induced fibrosarcomas , 1975, International journal of cancer.

[230]  J. Rhodin,et al.  Ultrastructure of mammalian venous capillaries, venules, and small collecting veins. , 1968, Journal of ultrastructure research.

[231]  E. Appella,et al.  Autocrine saturation of pro-urokinase receptors on human A431 cells , 1986, Cell.

[232]  H. D. Liggitt,et al.  Influence of migratory blood cells on the attachment of tumor cells to vascular endothelium , 1984, International journal of cancer.

[233]  D. Beebe,et al.  Hyaluronate in vasculogenesis. , 1983, Science.

[234]  A. Schreiber,et al.  Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain. , 1984, Science.

[235]  G. Nicolson,et al.  Tumor‐cell‐platelet aggregation does not correlate with metastatic potential of rat 13762NF mammary adenocarcinoma tumor cell clones , 1984, International journal of cancer.

[236]  T. Yednock,et al.  Phosphomannosyl-derivatized beads detect a receptor involved in lymphocyte homing , 1987, The Journal of cell biology.

[237]  J. Boyles,et al.  Vascular associations of mast cells in the diaphragm. , 1981, Microvascular research.

[238]  J. Varani,et al.  Directional motility in strongly malignant murine tumor cells , 1985, International journal of cancer.

[239]  T. Irimura,et al.  Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. , 1983, Science.

[240]  N. Kay.  Natural killer cells. , 1986, Critical reviews in clinical laboratory sciences.

[241]  Peter J. Polverini,et al.  Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene , 1989, Cell.

[242]  D. Schubert,et al.  A role of secreted glycosaminoglycans in cell-substratum adhesion. , 1980, The Journal of biological chemistry.

[243]  A. Kang,et al.  Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules. , 1980, The Journal of biological chemistry.

[244]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[245]  D. Spandidos,et al.  Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. , 1987, British Journal of Cancer.

[246]  R. Mecham,et al.  Elastin binds to a multifunctional 67-kilodalton peripheral membrane protein. , 1989, Biochemistry.

[247]  B. Zetter,et al.  Identification of a tumor cell receptor for VGVAPG, an elastin-derived chemotactic peptide , 1988, The Journal of cell biology.

[248]  D. Goeddel,et al.  Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.

[249]  Y. Courtois,et al.  Bovine retina contains three growth factor activities with different affinity to heparin: eye derived growth factor I, II, III. , 1985, Biochimie.

[250]  J. Zeuthen,et al.  Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin. , 1985, The Journal of biological chemistry.

[251]  B. Seed,et al.  Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. , 1989, Science.

[252]  P. L. Chen,et al.  Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. , 1988, Science.

[253]  I. Weissman,et al.  Homing receptors and metastasis. , 1988, Advances in cancer research.

[254]  E. Pardon,et al.  Specificity of adhesion between murine tumor cells and capillary endothelium: an in vitro correlate of preferential metastasis in vivo. , 1987, Cancer research.

[255]  I. Tannock,et al.  Quantitative techniques for study of the anatomy and function of small blood vessels in tumors. , 1969, Journal of the National Cancer Institute.

[256]  N. Ferrara,et al.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. , 1989, Biochemical and biophysical research communications.

[257]  S. Segal,et al.  Proteolytic enzymes in tumor metastasis. I. Plasminogen activator in clones of Lewis lung carcinoma and T10 sarcoma. , 1985, Journal of the National Cancer Institute.

[258]  W. Thompson,et al.  Fibrin degradation and angiogenesis: Quantitative analysis of the angiogenic response in the chick chorioallantoic membrane , 1985, The Journal of pathology.

[259]  B. Geiger,et al.  Motility and adhesive properties of high- and low-metastatic murine neoplastic cells. , 1984, Cancer research.

[260]  H. Neurath.  The versatility of proteolytic enzymes , 1986, Journal of cellular biochemistry.

[261]  G. Martin,et al.  Invasive activity and chemotactic response to growth factors by Kaposi's sarcoma cells , 1988, Journal of cellular biochemistry.

[262]  D. Lawrence,et al.  Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions , 1985 .

[263]  J. Folkman,et al.  Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois. Role of host and preexisting graft blood vessels. , 1975, The American journal of pathology.

[264]  M. Klagsbrun,et al.  Presence of heparin binding growth factor in mouse bladder tumors and urine from mice with bladder cancer. , 1986, Cancer research.

[265]  G. Nicolson,et al.  Metastatic tumor cells adhere preferentially to the extracellular matrix underlying vascular endothelial cells , 1980, International journal of cancer.

[266]  W. Konigsberg,et al.  Purification and characterization of bovine tissue factor. , 1981, The Journal of biological chemistry.

[267]  M. Sporn,et al.  Induction of transforming growth factor-α in activated human alveolar macrophages , 1988, Cell.

[268]  G. Markus,et al.  Plasminogen activator content of human colon tumors and normal mucosae: separation of enzymes and partial purification. , 1980, Journal of the National Cancer Institute.

[269]  G. Nicolson,et al.  Solubilization and degradation of subendothelial matrix glycoproteins and proteoglycans by metastatic tumor cells. , 1982, The Journal of biological chemistry.

[270]  D. S. Dimitrov,et al.  Mechanical aspects of the lungs as cancer cell-killing organs during hematogenous metastasis. , 1986, Journal of theoretical biology.

[271]  L. Schwartz,et al.  The fibrinogenolytic activity of purified tryptase from human lung mast cells. , 1985, Journal of immunology.

[272]  M. Klagsbrun,et al.  Endothelial cell mitogens derived from retina and hypothalamus: biochemical and biological similarities , 1984, The Journal of cell biology.

[273]  M. Nakajima,et al.  The role of polymorphonuclear leukocytes (PMN) on the growth and metastatic potential of 13762nf mammary adenocarcinoma cells , 1988, International journal of cancer.

[274]  L. Liotta,et al.  Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains , 1987, The Journal of cell biology.

[275]  A. Tohgo,et al.  Inhibitory effects of heparin plus cortisone acetate on endothelial cell growth both in cultures and in tumor masses. , 1987, Journal of the National Cancer Institute.

[276]  L. Liotta,et al.  The significance of hematogenous tumor cell clumps in the metastatic process. , 1976, Cancer research.

[277]  T. Murad,et al.  Role of the pericyte in wound healing. An ultrastructural study. , 1970, Experimental and molecular pathology.

[278]  T. K. Hunt,et al.  Role of Platelets and Fibrin in the Healing Sequence: An In Vivo Study of Angiogenesis and Collagen Synthesis , 1982, Annals of surgery.

[279]  Yukihide Iwamoto,et al.  Identification of an amino acid sequence in laminin mediating cell attachment, chemotaxis, and receptor binding , 1987, Cell.

[280]  C. Marshall,et al.  Enhanced spontaneous metastasis of mouse carcinoma cells transfected with an activated c‐Ha‐ras‐1 gene , 1986, International journal of cancer.

[281]  R. Nicosia,et al.  Angiogenesis-dependent tumor spread in reinforced fibrin clot culture. , 1983, Cancer research.

[282]  S. Schwartz,et al.  Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. , 1986, Science.

[283]  B. Zetter,et al.  Stimulation of mast cell chemotaxis by interleukin 3 , 1989, The Journal of experimental medicine.

[284]  T. K. Hunt,et al.  Effect of lactate, pyruvate, and pH on secretion of angiogenesis and mitogenesis factors by macrophages. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[285]  D. Ingber,et al.  A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. , 1988, The American journal of pathology.

[286]  P. Bohlen,et al.  Isolation of fibroblast growth factor from bovine adrenal gland: physicochemical and biological characterization. , 1986, Endocrinology.

[287]  R. Juliano,et al.  Membrane receptors for extracellular matrix macromolecules: relationship to cell adhesion and tumor metastasis. , 1987, Biochimica et biophysica acta.

[288]  W. Ershler,et al.  Investigation of tumor angiogenesis in an id mouse model: role of host-tumor interactions. , 1988, Journal of the National Cancer Institute.

[289]  D. Rifkin,et al.  Interaction of heparin with human basic fibroblast growth factor: Protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan , 1989, Journal of cellular physiology.

[290]  B. Zetter.  The Endothelial Cells of Large and Small Blood Vessels , 1981, Diabetes.

[291]  J. Roberts,et al.  Cathepsin B-like enzymes. Subcellular distribution and properties in neoplastic and control cells from human ectocervix. , 1981, The Journal of biological chemistry.

[292]  M. Hendrix,et al.  In vitro assay demonstrates similar invasion profiles for B16F1 and B16F10 murine melanoma cells. , 1986, Cancer letters.

[293]  A. Raz.  Actin organization, cell motility, and metastasis. , 1988, Advances in experimental medicine and biology.

[294]  S. Rybak,et al.  Base cleavage specificity of angiogenin with Saccharomyces cerevisiae and Escherichia coli 5S RNAs. , 1988, Biochemistry.

[295]  E. Manseau,et al.  Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. , 1979, Journal of the National Cancer Institute.

[296]  Orhan K Öz,et al.  Reduced cell adhesion to fibronectin and laminin is associated with altered glycosylation of β1, integrins in a weakly metastatic glycosylation mutant , 1989, International journal of cancer.

[297]  D. Rowe,et al.  Collagen and collagen-derived fragments are chemotactic for tumor cells. , 1981, The Journal of clinical investigation.

[298]  K. Bensch,et al.  Isolation and growth of endothelial cells from the microvessels of the newborn human foreskin in cell culture. , 1980, The Journal of investigative dermatology.

[299]  J. Folkman,et al.  Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. , 1989, Biochemistry.

[300]  J. McCarthy,et al.  Human fibronectin contains distinct adhesion- and motility-promoting domains for metastatic melanoma cells , 1986, The Journal of cell biology.

[301]  D. Rifkin,et al.  Role of extracellular matrix in the action of basic fibroblast growth factor: Matrix as a source of growth factor for long‐term stimulation of plasminogen activator production and DNA synthesis , 1989, Journal of cellular physiology.

[302]  A. Schor,et al.  The effects of fibronectin on the migration of human foreskin fibroblasts and Syrian hamster melanoma cells into three-dimensional gels of native collagen fibres. , 1981, Journal of cell science.

[303]  Z. Werb,et al.  [15] Elastin degradation , 1987 .

[304]  I. Fidler,et al.  Tumor heterogeneity and the biology of cancer invasion and metastasis. , 1978, Cancer research.

[305]  W. Birchmeier,et al.  Monoclonal antibodies which prevent experimental lung metastases , 1984, FEBS letters.

[306]  G. Vaes,et al.  Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. , 1977, The Biochemical journal.

[307]  J. Fiddes,et al.  Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. , 1986, Science.

[308]  V. Terranova,et al.  Human endothelial cells are chemotactic to endothelial cell growth factor and heparin , 1985, The Journal of cell biology.

[309]  R. Shapiro,et al.  Characteristic ribonucleolytic activity of human angiogenin. , 1986, Biochemistry.

[310]  T. Salo,et al.  Proteolytic degradation of extracellular matrix in tumor invasion. , 1987, Biochimica et biophysica acta.

[311]  L. Liotta,et al.  Partial purification and characterization of a neutral protease which cleaves type IV collagen. , 1981, Biochemistry.

[312]  L. Liotta,et al.  Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. , 1988, Cancer research.

[313]  K. Kurachi,et al.  Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor. , 1985, Biochemistry.

[314]  C. Harris,et al.  Invasive and metastatic potential of a v-Ha-ras-transformed human bronchial epithelial cell line. , 1989, Journal of the National Cancer Institute.

[315]  D. Tarin,et al.  Analysis of organ-specific effects on metastatic tumor formation by studies in vitro. , 1986, Journal of the National Cancer Institute.

[316]  M. Zeydel,et al.  Collagenase and elastase production by mouse mammary adenocarcinoma primary cultures and cloned cells. , 1986, Cancer research.

[317]  W. Carter,et al.  Mechanism of fibronectin-mediated cell migration: dependence or independence of cell migration susceptibility on RGDS-directed receptor (integrin). , 1989, Experimental cell research.

[318]  D. Benezra.  Neovasculogenic ability of prostaglandins, growth factors, and synthetic chemoattractants. , 1978, American journal of ophthalmology.

[319]  K. Nabeshima,et al.  Monoclonal antibody preparation and purification of a tumor cell collagenase-stimulatory factor. , 1989, Cancer research.

[320]  D. Gospodarowicz,et al.  Heparin protects basic and acidic FGF from inactivation , 1986, Journal of cellular physiology.

[321]  V. Kinzel,et al.  Cancer: Experiments and Concepts , 1977 .

[322]  J. McCarthy,et al.  Migration by haptotaxis of a Schwann cell tumor line to the basement membrane glycoprotein laminin , 1983, The Journal of cell biology.

[323]  G. Gasic,et al.  Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)amide. , 1981, Cancer research.

[324]  P A D'Amore,et al.  Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells , 1987, The Journal of cell biology.

[325]  H. Birkedal‐Hansen,et al.  Activation of fibroblast procollagenase by mast cell proteases. , 1976, Biochimica et biophysica acta.

[326]  G. diZerega,et al.  Initiation of angiogenesis by human follicular fluid. , 1984, Science.

[327]  I. Fidler,et al.  Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. , 1980, Cancer research.

[328]  T. J. Ryan.  FACTORS INFLUENCING THE GEOWTH OF VASCULAR ENDOTHELIUM IN THE SKIN , 1970 .

[329]  L. Liotta,et al.  Identification of a type V collagenolytic enzyme. , 1981, Biochemical and biophysical research communications.

[330]  M. Klagsbrun,et al.  Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells , 1989, The Journal of cell biology.

[331]  P. Kumar,et al.  Isolation and characterization of endothelial cells from rat and cow brain white matter. , 1979, Journal of anatomy.

[332]  M. D. Bond,et al.  Isolation of bovine angiogenin using a placental ribonuclease inhibitor binding assay. , 1988, Biochemistry.

[333]  R. Mecham,et al.  Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes , 1984, The Journal of cell biology.

[334]  B. Fisher,et al.  Anticoagulants and tumor cell lodgement. , 1967, Cancer research.

[335]  A. Barrett,et al.  Cathepsin B1. A lysosomal enzyme that degrades native collagen. , 1974, The Biochemical journal.

[336]  D. Belin,et al.  Increase of urokinase-type plasminogen activator gene expression in human lung and breast carcinomas. , 1987, Cancer research.

[337]  H. Dvorak,et al.  Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. , 1989, Biochimica et biophysica acta.

[338]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[339]  N. Catsimpoolas,et al.  Lipid angiogenic factor from omentum. , 1984, JAMA.

[340]  B. Zetter,et al.  Migration of capillary endothelial cells is stimulated by tumour-derived factors , 1980, Nature.

[341]  B. Zetter,et al.  Stimulation of human vascular endothelial cell growth by a platelet-derived growth factor and thrombin. , 1979, Journal of supramolecular structure.

[342]  A. Recklies,et al.  Secretion of proteinases from malignant and nonmalignant human breast tissue. , 1980, Cancer research.

[343]  A. Vaheri,et al.  Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells , 1987, The Journal of cell biology.

[344]  A. Kato,et al.  Quantitative autoradiographic measurements of blood-brain barrier permeability in the rat glioma model. , 1982, Journal of neurosurgery.

[345]  B. Beutler,et al.  Cachectin and tumour necrosis factor as two sides of the same biological coin , 1986, Nature.

[346]  G. Nicolson,et al.  Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular endothelial integrity. , 1985, Cancer research.

[347]  R. Silverstein,et al.  Activation of immobilized plasminogen by tissue activator. Multimolecular complex formation. , 1985, The Journal of biological chemistry.

[348]  S. Rybak,et al.  Angiogenin mRNA in human tumor and normal cells. , 1987, Biochemical and biophysical research communications.

[349]  B. Vallee,et al.  Human angiogenin, an organogenic protein. , 1988, British Journal of Cancer.

[350]  Z. Fuks,et al.  Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis. , 1983, Cancer research.

[351]  L. Matrisian,et al.  Structure-function relationships in the collagenase family member transin. , 1988, The Journal of biological chemistry.

[352]  S Parodi,et al.  Chemotaxis of 3T3 and SV3T3 cells to fibronectin is mediated through the cell-attachment site in fibronectin and a fibronectin cell surface receptor , 1987, The Journal of cell biology.

[353]  H. Greene,et al.  THE RELATIONSHIP BETWEEN THE DISSEMINATION OF TUMOR CELLS AND THE DISTRIBUTION OF METASTASES. , 1964, Cancer research.

[354]  S. O’Brien,et al.  Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization. , 1986, Science.

[355]  J. Folkman,et al.  Angiogenic activity of adipose tissue. , 1988, Biochemical and biophysical research communications.

[356]  J. Folkman,et al.  How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. , 1986, Cancer research.

[357]  B. Zetter,et al.  Urine from patients with transitional-cell carcinoma stimulates migration of capillary endothelial cells. , 1981, The New England journal of medicine.

[358]  Bonnie F. Sloane,et al.  Lysosomal cathepsin B: correlation with metastatic potential. , 1981, Science.

[359]  E Ruoslahti,et al.  New perspectives in cell adhesion: RGD and integrins. , 1987, Science.

[360]  B. Zetter,et al.  Absence of mast cells in diabetic retinopathy. , 1982, Microvascular research.

[361]  N. Hanna.  Inhibition of experimental tumor metastasis by selective activation of natural killer cells. , 1982, Cancer research.

[362]  D. Connolly,et al.  Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. , 1989, The Journal of clinical investigation.

[363]  K. Miyazono,et al.  Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor , 1989, Nature.

[364]  J. Folkman,et al.  Inhibition of tumor angiogenesis mediated by cartilage , 1975, The Journal of experimental medicine.